Learning Objectives
I Histamine Pharmacological effects Histamine and Antihistamines Sites of action Conditions which cause release Aron H. Lichtman, Ph.D. Diagnostic uses Associate Professor II Antihistamines acting at the H1 and H2 receptor Pharmacology and Toxicology Pharmacological effects Mechanisms of action Therapeutic uses Side effects and drug interactions Be familiar with the existence of the H3 receptor III Be able to describe the main mechanism of action of cromolyn sodium and its clinical uses
Histamine Pharmacology First autacoid to be discovered. (Greek: autos=self; Histamine Formation akos=cure) Synthesized in 1907 Synthesized in mammalian tissues by Demonstrated to be a natural constituent of decarboxylation of the amino acid l-histidine mammalian tissues (1927) Involved in inflammatory and anaphylactic reactions. Local application causes swelling redness, and edema, mimicking a mild inflammatory reaction. Large systemic doses leads to profound vascular changes similar to those seen after shock or anaphylactic origin
Histamine Stored in complex with:
Heparin Chondroitin Sulfate Eosinophilic Chemotactic Factor Neutrophilic Chemotactic Factor Proteases
1 Conditions That Release Histamine 1. Tissue injury: Any physical or chemical agent that injures tissue, skin or mucosa are particularly sensitive to injury and will cause the immediate release of histamine from mast cells.
2. Allergic reactions: exposure of an antigen to a previously sensitized (exposed) subject can immediately trigger allergic reactions. If sensitized by IgE antibodies attached to their surface membranes will degranulate when exposed to the appropriate antigen and release histamine, ATP and other mediators.
3. Drugs and other foreign compounds: morphine, dextran, antimalarial drugs, dyes, antibiotic bases, alkaloids, amides, quaternary ammonium compounds, enzymes (phospholipase C). Penicillins, Tetracyclines, Basic drugs- amides, amidines, diamidines, Toxins, venoms, Proteolytic enzymes, Bradykinin, Kallidin, & Substance P
3 Types of Histamine Receptors Pharmacological Effects of Histamine 1. Cardiovascular system. 1. H1 receptors: mediate effects on smooth muscle a) triple effect on terminal vasculature (itching & pain): leading to vasodilation, increased vascular i. reddening at injection site due to vasodilation permeability, and contraction of nonvascular ii. wheal or disk of edema within 1 to 2 min iii. a large, bright crimson flare or halo surrounding the wheal smooth muscle. b) i.v. histamine: fall in blood pressure, cutaneous flushing, over the face and upper trunk, rise in skin temperature, intense headache. 2. H receptors: mediate histamine stimulation of 2. Smooth muscle of bronchioles; causes contraction of nonvascular 2 smooth muscle. Asthmatics may experience marked bronchial gastric acid secretion and may be involved in constriction compared with normal subjects. cardiac stimulation. 3. Exocrine glands: potent stimulator of gastric secretion (HCl & pepsin), enhances salivary and lacrimal gland secretion (minimal unless large doses are given), stimulates chromaffin cells in adrenal 3. H3 receptors: feedback inhibitors in CNS, medulla to secrete catecholamines. gastrointestinal tract, lung, heart. 4. Peripheral Nervous system: itching and pain
Pharmacological Effects: Pharmacological Effects: Exocrine Glands Arterioles, Capillaries & Venules
Gastric glands Salivary glands Vasodilation Sweat glands Pancreas Secretion Increased permeability, (edema) Bronchial glands Lacrimal glands Systemic hypotension
2 Pharmacological Effects Effects: Vascular Smooth Muscles Antihistamines Background
Daniel Bovet, Nobel Prize 1944 Bronchial tree Synthesized first antihistamines Compounds appeared to prevent the binding of histamine to H receptors through their Gastrointestinal tract Contraction 1 structural similarities
Uterus
General Mechanism of Action of Histamine vs. Antihistamine Antihistamines Cardiovascular Effects
Blocks action of histamine at receptor Histamine dilation of small blood vessels / increased Competes with histamine for binding permeability
Displaces histamine from receptor Antihistamine Most beneficial when given early prevents dilation / prevents increased permeability
Histamine Decreases Blood Pressure Histamine vs. Antihistamine: Smooth Muscle Effects
Histamine Stimulates exocrine glands (salivary, gastric, lacrimal, & bronchial secretions)
Antihistamine prevents: salivary, gastric, lacrimal, & bronchial secretions
3 Histamine vs. Antihistamine: Diagnostic Uses of Histamine Immune Effects
Histamine 1. Sampling gastric acid content, 1 mg histamine mast cell release: histamine & other substances released subcutaneously to stimulate gastric secretion (no major effects on blood vessels).
Antihistamine 2. Pulmonary function (for diagnosing asthma). bind to receptors and prevents histamine from eliciting a response 3. Sensory nerve function.
Therapeutic Uses of H1 Blockers Actions Not Caused by H1 Receptor Blockade 1. Allergic rhinitis, relieves rhinorrhea, sneezing, and itching of eyes and nasal mucosa. 1. antinausea and antiemetic effects 2. Common cold: palliative, dries out the nasal mucosa. Often combined with nasal decongestant and analgesics. (antimuscarinic effects) 3. Allergic dermatoses: can control itching associated with insect bites. 2. antiparkinsonism effects (antimuscarinic 4. Outpatient procedures for preanesthetic sedation and prevention of effects) nausea and vomiting (Promethazine (Phenergan)). Phenergan also inhibits salivary and bronchial secretions and can be used as a local 3. peripheral antimuscarinic effects anesthetic. 4. adrenoceptor-blocking actions 5. Antiemetic: prevention or treatment of nausea and vomiting (phenothiazines) (Bendectin, doxylamine with pyridoxine). 6. Hypnotics: limited value. 5. manifested as orthostatic hypotension 7. Other uses: 6. serotonin-blocking action (cyproheptadine) a. Reduction of tremors and muscle rigidity in Parkinson's disease 7. local anesthesia, blockade of sodium channels b. Treatment of migraine headaches (diphenhydramine and promethazine)
Toxic Reactions & Side Effects of Mechanism of Action: H1 Antagonists H1 Blockers 1. CNS depression (mainly in first generation agents). Displaces histamine from the H1 receptor, which is a G-protein coupled receptor 2. Allergic reactions (topical application). 3. Appetite loss, nausea and vomiting, constipation or Histamine leads to formation of IP3 and a release diarrhea. of stored Ca++, followed by a cascade of other 4. Insomnia, tremors, nervousness, irritability, events. tachycardia, dry mouth, blurred vision, urinary retention, constipation (1st generation). 5. CNS stimulation with hallucinations, motor H1 receptor blockade prevents this activity and leads to a decrease in Ca++ inside of the cell disturbances (tremors and convulsions), and death. 6. Secreted in breast milk and can cross the placenta.
4 Drug Interactions of H1 Blockers First Generation Antihistamines 1. Antihistamines that produce sedation can potentiate CNS depressants (e.g., barbiturates, opiates, general Side Effects anesthetics, and alcohol) Sedating 2. Antihistamines that possess anticholinergic actions can produce manifestations of excessive blockade if Anticholinergic given with anticholinergic drugs (e.g., dry mouth, Many available Over- the- Counter (OTC) constipation, or blurred vision) Inexpensive (Average $4.50/pack) 3. Terfenadine (Seldane) taken with grapefruit juice or erythromycin or other drugs that inhibit the enzyme, 56% of allergy sufferers use OTC, but only CYP3A4 can lead to cardiac toxicity. Taken off the $325 million in sales market.
First Generation Antihistamines First Generation Antihistamines (Alkylamines) 1. Alkylamines Chlorpheniramine maleate 2. Ethanolamines (Chlor Trimeton®) 3. Ethylenediamines Schering (1949) 4. Piperazines Currently sold OTC by 5. Phenothiazines Schering-Plough 6. Piperadines Healthcare Products
First Generation Antihistamines (Ethanolamines) First Generation Antihistamines (Piperadines)
Diphenhydramine HCl (Benadryl®) Parke Davis (1946) Azatadine (Optimine®) Currently sold OTC by Pfizer, Schering (1977) Inc., Warner -Lambert Available only by Consumer Healthcare prescription
5 First Generation Antihistamines First Generation Antihistimines (Piperazines) (Phenothiazines) Hydroxyzine HCl (Atarax®) Promethazine HCl (Phenergan®) Pfizer (1956) Wyeth (1951) Available only by prescription Available only by prescription
Second Generation Antihistamines: Second Generation Antihistamines Terfenadine (Seldane®) Non-sedating Generally do not cause the sedation and drying seen Caused fatal heartbeat irregularities when taken with in first generation antihistamines certain drugs and foods Do not cross the blood-brain barrier as readily as Ketoconozole, erithromycin, grapefruit juice First Generation compounds interfered with drug metabolism increasing the concentration of terfenadine in bloodstream Lipophobicity Removed from the market (1992) Large molecular size Electrostatic charge
Second Generation Antihistamines: Second Generation Antihistamines: Fexofenadine HCl(Allegra®) Loratadine (Claritin®) Safe metabolite of Terfenadine FDA approved on July 25, 1996 Schering-Plough, Inc. FDA approved 1993 Non-sedating (FAA, Air force, Navy approved) Developed from Azatadine Clinical studies showed no cardiac side effects Non-sedating (FAA, Air force, Navy approved) No reported cardiac side effects up to 160 mg
6 Second Generation Antihistamines: Specificity of Selected H Blockers Cetirizine (Zyrtec®) 1
Pfizer, Inc and UCB Pharma Inc. FDA approved 1995 Metabolite of hydroxyzine Effective against rash/hives No reported cardiac side effects Potential for sedation
H2 Antagonist Pharmacological Effects 1. Competitive antagonists at the H receptors OTC Available H Antagonists 2 2 2. Inhibits secretory function of gastric mucosa. 3. Few other effects than those on gastric secretion. 4. Reduces gastric acid volume & concentration of pepsin 1. cimetidine (Tagamet) associated with most side effects Most Common Adverse Effects 1. Diarrhea 2. rantidine (Zantac) 2. Dizziness 3. famotidine (Pepcid) 3. Somnolence 4. nizatidine (Axid) 4. Headache 5. Rash 6. Constipation 7. Vomiting 8. Arthralgia
H2 Blockers Decrease Gastric Acid H Antagonist Therapeutic Uses Release 2 1. Duodenal ulcer 2. Gastric ulcer 3. Zollinger-Ellison syndrome (a pathological hypersecretory state resulting in excessive gastric pepsin & HCl) 4. Gastroesophageal reflux disease 5. Used prior to surgery in patients with GI obstruction to elevate gastric pH 6. Reflux esophagitis 7. Antacid
7 Toxic Reactions (Mostly Associated With Cimetidine (Tagamet)) H2 Antagonists: Mechanisms of Action 1. Most common (seen in only 1-2% of patients): diarrhea, dizziness, somnolence, headache, and rash. Displaces histamine from the H receptor, a Also constipation, vomiting and arthralgia. 2 2. CNS effects: slurred speech, delirium, confusion. G-protein coupled receptor Most commonly seen in older patients or those with Because histamine activates cAMP, H2 liver or kidney impairment blockers lead to a decrease in cAMP and 3. Endocrine function (minor and reversible): a concomitant decrease in Ca++ antiandrogen effects, e.g., loss of libido, impotence, reduced sperm count 4. Blood dyscrasias. 5. Liver: reversible cholestasis.
H2 Antagonist Drug Interaction H3 Receptor Drugs Cimetidine: increased activity of drugs that are metabolized through cytochrome P450 pathway and also reduces Believed to act as feedback inhibitors in a wide variety of organ systems in the CNS, agonists cause sedation blood flow through the liver including. e.g., warfarin, phenytoin, propanolol, metoprolol, quinidine, caffeine, GI: agonists down regulate histamine. Thereby decreasing gastrin lidocaine, theophylline, benzodiazepines, ethanol, tricyclic antidepressants, and calcium channel blockers. Lung: agonists have a bronchodilatory effect
All H2 blockers except famotidine (Pepcid) increase the bioavailability of ethanol. Clinical Uses Agents that inhibit gastric secretion alter the bioavailability None (Drugs are available only for research purposes) and rate of absorption of many other drugs Mechanisms of Action G-protein coupled receptor, decreases of intracellular Ca++
Inhibitors of Histamine Release Histamine Release Inhibitors: Cromolyn sodium (Intal, Nasalcrom) Therapeutic Uses Nedocromil Sodium mild to moderate bronchial asthma to prevent asthma attacks. in vitro studies : Reduces the release of histamine, other granular contents & leukotriene production. effective in children Devoid of bronchodilating capability reduces need of steroid or bronchodilators Inhibits pulmonary mast cell degranulation in response to a ineffective for an acute attack variety of stimuli including the interaction between cell- becomes effective over time (e.g. 2-3 weeks) bound IgE and specific antigen. allergic rhinitis Does not relax bronchial or other smooth muscle in vitro or, atopic diseases of the eye in the short term, in vivo. However, long term giant papillary conjuctivitis administration diminishes bronchial hyperactivity.
8 Histamine Release Inhibitors Learning Objectives I Histamine Dosage form Pharmacological effects aerosol powder (Intal) and solution - asthma Sites of action nasal spray (Nasalcrom) - allergic rhinitis Conditions which cause release Diagnostic uses optic solution 4% - (Opticrom) - allergic conjunctivitis II Antihistamines acting at the H1 and H2 receptor Pharmacological effects Toxicity Mechanisms of action well tolerated, few adverse reactions Therapeutic uses irritation due to powder inhalation Side effects and drug interactions Be familiar with the existence of the H3 receptor Stinging, Burning, Bad Taste III Be able to describe the main mechanism of action of Coughing, sneezing, allergic reactions cromolyn sodium and its clinical uses
Practice Questions Practice Questions 1) Which of the following antihistamines is most likely to 3) Which of the following statements about antihistamines are correct? potentiate the CNS depressant effects of alcohol? A. antihistamines prevent histamine release A. Promethazine (Phenergan) B. antihistamines produce their effects through competition at the B. Loratadine (Claritin) receptor C. Rantidine (Zantac) C. antihistamines promote histamine degradation D. Chlorpheniramine (Chlor-Trimeton) D. antihistamines prevent histamine synthesis E. none of the above E. all of the above statements are correct
2) Rantidine (Zantac), an H2 receptor antagonist, is most likely to 4) Which of the following effects is NOT associated with histamine? produce which of the following effects? A. triple effect A. inhibition of the "triple effect" of histamine B. progressive fall in blood pressure B. inhibition of gastric secretions C. headache C. inhibition of nausea and vomiting D. secretion of catecholamines from chromaffin cells in adrenal D. sedation medulla E. inhibition of salivary and bronchial secretions E. sedation
Practice Questions Practice Questions 5) Which of the following drugs would be the best treatment for 7) Antihistamines acting at the ______receptor are most likely to allergic rhinitis if you operated heavy machinery? ______.
A. diphenhydramine (Benadryl) A. H1 receptor; inhibit the "triple effect" of histamine B. nizatidine (Axid) B. H2 receptor; inhibit the "triple effect" of histamine C. promethazine (Phenergan) C. H1 receptor; reverse anaphylaxis D. fexofenadine (Allegra) D. H2 receptor; reverse anaphylaxis E. rantidine (Zantac) E. H1 receptor; block gastric secretions
6) Nizatidine (Axid) an H2 antagonist, can be effectively used for 8) Which of the following effects is most commonly associated with the control of _____. histamine? A. itching associated with insect bites A. progressive increase in blood pressure B. asthma B. progressive decrease in blood pressure C. indigestion C. decrease in gastric secretions D. the triple effect D. triple effect E. insomnia E. sedation
9